4^th International Pharma & Clinical Pharmacy Congress Nov 07-09, 2016 Las Vegas, Nevada, USA

Minhao Xie has completed his B.S. from Nanjing University and Ph.D. from Jiangnan University. He is now the professor and directior at Jiangsu Institute of Nuclear Medicine with the research interest of bisphosphonates for the diagnosis and treatment of cancer. He has published more than eighty research papers and obtained more than twenty Chinese patents.

Bisphosphonates for the diagnosis and treatment of cancer

Benmansour zakaria1. university of medcin, oran, algeria. doctor in University of Medical Sciences " Oran Algeria On Parasitology and mycology medical "Laboratory of The University Hospital , Oran he is a researcher in the laboratory of infectious diseases and biologically active substances in the faculty of medicine of Oran .Algeria . His research work focuses on molecular fungal and virology and vaccinology Ph.d. In parasitology and mycology department of medicine of Oran Algeria.

His research included work on mycology and parasitology infections.

Dong-Hwan Lee has completed his PhD at the age of 35 years from Yonsei University College of Medicine. He is an assistant professor of clinical pharmacology in the department of clinical pharmacology and the manager of the clinical pharmacology division of the clinical trial center in Pusan National University Hospital. He has published 13 papers in reputed journals.

clinical pharmacology

Irena Kostova is a full professor in the Faculty of Pharmacy, Medical University-Sofia. Her PhD and DSc Theses have been awarded by Medical University-Sofia. She has established, promoted and maintains relationships with many European and Asian Universities through joint research projects and programs. She has been a member of advisory and organizing committees of many international conferences. Prof. Kostova is an Editor and a member of the Editorial and Advisory Boards of 16 international journals. She has been a reviewer for many high ranking journals and international projects. She has published hundreds of publications with more than 3000 citations (h-index: 27).

Pharmaceutical Sciences

Dr Chidi Nweneka is a Paediatrician, Epidemiologist, Clinical Scientist, Advocacy Expert, and Strategist with research interests in antimicrobial resistance, HIV, reproductive health and malaria. He also has a PhD degree in Child Health and Human Nutrition from the University of Glasgow, UK. Chidi is currently the Deputy Director, Policy and Strategy Department, and head of the Strategy and Planning Division of the National Agency for The Control of AIDS, Nigeria. Prior to this, he was the Deputy Director Public Health Programs and Policy (and the PEPFAR Lead) for the US Department of Defense Walter Reed Program, Nigeria. He was also the Executive Director of the African AIDS Vaccine Partnership (AAVP). He served as a member of the Civil Society Working Group for the Microbicide Development Strategy (2006 -2007). Dr Nweneka has been involved in National and International vaginal microbicides advocacy since 2001 and served as a member of the Scientific Review Committee – HIV Microbcides for the European and Developing Countries Clinical Trials Partnership (EDCTP).

Antimicrobial resistance, HIV, reproductive health and malaria